|Bid||155.05 x 800|
|Ask||155.06 x 1100|
|Day's Range||153.26 - 155.66|
|52 Week Range||93.23 - 162.70|
|Beta (5Y Monthly)||1.11|
|PE Ratio (TTM)||16.17|
|Earnings Date||Jul 26, 2021 - Jul 30, 2021|
|Forward Dividend & Yield||0.28 (0.18%)|
|Ex-Dividend Date||Jul 15, 2021|
|1y Target Est||159.71|
These are the healthcare stocks with the best value, fastest growth, and most momentum for July 2021.
PerkinElmer (PKI) expects to be able to support its cell and gene therapy workflows, and expand its existing research solutions via the latest buyout.
PerkinElmer (PKI), a leading name in medical technology, recently announced the acquisition of SIRION Biotech GmbH, a provider of viral vector-based technologies. The transaction is likely to close in the third quarter of 2021. The terms of the deal have not been disclosed yet. Following the news, shares of the company rose marginally to close at $153.20 in Tuesday’s trading session. CEO of PerkinElmer Prahlad Singh said, “By combining SIRION’s innovative “payload” transport technology with our